miRNA articles & resources on Made-in-China.com

Santaris Pharma and miRagen Therapeutics Have Extended Their Research Deal

Jan 14, 2013

Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...

Tags: Santaris Pharma, miRagen Therapeutics, microRNAs

ISO Certification Is Granted by HTG Molecular qNPA Technology

Dec 18, 2012

HTG Molecular Diagnostics has obtained ISO 13485:2003 certification for the design, manufacture, and distribution of its patented qNPA technology-based products and services used in the analysis of gene expression. qNPA molecular ...

Tags: ISO Certification, analysis of gene expression, medical technology

Ventana Medical Systems Launched a New Fully-Automated Staining Technique

Dec 7, 2012

Ventana Medical Systems, a member of the Roche Group, has launched a new fully-automated staining technique that allows researchers to visualize miRNAs and proteins related to cancer in the same section of tumor tissue. Detection of ...

Tags: Ventana, staining technique, cancer detection, miRNAs

Ventana Medical Systems Has Introduced a Fully-Automated Staining Technique

Dec 4, 2012

Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...

Tags: Ventana Medical Systems, miRNAs, proteins related to cancer

Genisphere and LIMR Will Continue Their Colloboration on microRNA Biomarker Development

Nov 29, 2012

Genisphere and the Lankenau Institute for Medical Research (LIMR) will continue their colloboration on microRNA (miRNA) biomarker development for Ulcerative Colitis (UC) and will expand the partnership to include Crohn's Disease and other ...

Tags: LIMR, miRNA, microRNA

USPTO Has Granted a Notice of Allowance to Silence Therapeutics

Nov 27, 2012

The US Patent and Trademark Office(USPTO)has granted a Notice of Allowance(NOA)to Silence Therapeutics for claims related to interfering RNA molecules and lipid complexes used in drug delivery. The NOA,which is issued based on the ...

Tags: Silence Therapeutics, RNAi therapeutics, Silence Company, RNA molecules